Inhibrx | Discover our clinical-stage biotechnology company.
Inhibrx Biosciences is a clinical-stage biopharmaceutical company developing biologic therapeutics for people with life-threatening conditions. Leveraging deep protein engineering expertise, the company has two lead clinical programs — ozekibart (INBRX-109) in sarcoma and INBRX-106 in head and neck cancer. The team combines scientific rigor with the agility of a startup to advance novel immunotherapy candidates.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2023
Aug 2020
Apr 2020
Apr 2018
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
